Cardiology Despite the availability of effective therapies, ischaemic heart disease remains the leading cause of death around the world. Early and proper diagnosis is key to reducing cardiovascular mortality and diagnostic imaging plays a crucial role here.

Oncology According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common. At Bracco, we are proud to be able to help bring that number down.

Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

The Bracco Fellowships are back 95 grants to celebrate Bracco’s 95th Anniversary

BIPSO further strengthens environmental protection BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Gadopiclenol: another milestone achieved Bracco Imaging and Guerbet have a worldwide collaboration on Gadopiclenol, an investigational macrocyclic gadolinium-based contrast agent (GBCA).

Distributors list Distributors list

Product template

Data protection Data Protection